Please use this identifier to cite or link to this item:
Title: Effects of polycaprolactone-based scaffolds on the blood-brain barrier and cerebral inflammation
Authors: Choy, David Kim Seng
Nyein, Mya Aye
Lu, Jia
Nga, Vincent Diong Weng
Lim, Jing
Chou, Ning
Yeo, Tseng Tsai
Teoh, Swee-Hin
Keywords: DRNTU::Science::Medicine::Tissue engineering
Issue Date: 2015
Source: Nga, V. D. W., Lim, J., Choy, D. K. S., Nyein, M. A., Lu, J., Chou, N., et al. (2015). Effects of polycaprolactone-based scaffolds on the blood-brain barrier and cerebral inflammation. Tissue engineering part A, 21(3-4), 647-653.
Series/Report no.: Tissue engineering part A
Abstract: Severe pathoanatomical and mechanical injuries compromise patient recovery and survival following penetrating brain injury (PBI). The realization that the blood–brain barrier (BBB) plays a major role in dictating post-PBI events has led to rising interests in possible therapeutic interventions through the BBB. Recently, the choroid plexus has also been suggested as a potential therapeutic target. The use of biocompatible scaffolds for the delivery of therapeutic agents, but little is known about their interaction with cerebral tissue, which has important clinical implications. Therefore, the authors have sought to investigate the effect of polycaprolactone (PCL) and PCL/tricalcium phosphate (PCL/TCP) scaffolds on the maintenance of BBB phenotype posttraumatic brain injury. Cranial defects of 3 mm depth were created in Sprague Dawley rats, and PCL and PCL/TCP scaffolds were subsequently implanted in predetermined locations for a period of 1 week and 1 month. Higher endothelial barrier antigen (EBA) expressions from PCL-based scaffold groups (p>0.05) were found, suggesting slight advantages over the sham group (no scaffold implantation). PCL/TCP scaffold group also expressed EBA to a higher degree (p>0.05) than PCL scaffolds. Importantly, higher capillary count and area as early as 1 week postimplantation suggested lowered ischemia from the PCL/TCP scaffold group as compared with PCL and sham. Evaluation of interlukin-1β expression suggested that the PCL and PCL/TCP scaffolds did not cause prolonged inflammation. BBB transport selectivity was evaluated by the expression of aquaporin-4 (AQP-4). Attenuated expression of AQP-4 in the PCL/TCP group (p<0.05) suggested that PCL/TCP scaffolds altered BBB selectivity to a lower degree as compared with sham and PCL groups, pointing to potential clinical implications in reducing cerebral edema. Taken together, the responses of PCL-based scaffolds with brain tissue suggested safety, and encourages further preclinical evaluation in PBI management with these scaffolds.
ISSN: 1937-3341
DOI: 10.1089/ten.tea.2013.0779
Schools: School of Chemical and Biomedical Engineering 
Rights: © 2015 Mary Ann Liebert. This paper was published in Tissue Engineering Part A and is made available as an electronic reprint (preprint) with permission of Mary Ann Liebert. The paper can be found at the following official DOI: [].  One print or electronic copy may be made for personal use only. Systematic or multiple reproduction, distribution to multiple locations via electronic or other means, duplication of any material in this paper for a fee or for commercial purposes, or modification of the content of the paper is prohibited and is subject to penalties under law.
Fulltext Permission: open
Fulltext Availability: With Fulltext
Appears in Collections:SCBE Journal Articles

Citations 20

Updated on Jul 10, 2024

Web of ScienceTM
Citations 20

Updated on Oct 25, 2023

Page view(s) 20

Updated on Jul 13, 2024

Download(s) 50

Updated on Jul 13, 2024

Google ScholarTM




Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.